Variant report
Variant | esv2608977 |
---|---|
Chromosome Location | chr6:134091567-134093190 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:104484256..104485211-chr6:134091919..134092643,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184157462 | chr6:134091592-134091593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554297258 | chr6:134091617-134091618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576974597 | chr6:134091662-134091663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs528786978 | chr6:134091684-134091685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188180937 | chr6:134091698-134091699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551334153 | chr6:134091728-134091729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541113434 | chr6:134091763-134091764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs35496668 | chr6:134091769-134091770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs111677313 | chr6:134091777-134091778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs73561588 | chr6:134091808-134091809 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567795741 | chr6:134091822-134091823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs367743312 | chr6:134091831-134091832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs559232430 | chr6:134091844-134091845 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs10485156 | chr6:134091859-134091860 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs547890097 | chr6:134091860-134091861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561215614 | chr6:134091914-134091915 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs377076302 | chr6:134091953-134091954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1208228 | chr6:134091966-134091967 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs534938327 | chr6:134091992-134091993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192386556 | chr6:134092003-134092004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184763409 | chr6:134092017-134092018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs73561590 | chr6:134092040-134092041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs556769780 | chr6:134092055-134092056 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549919470 | chr6:134092096-134092097 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs142547440 | chr6:134092128-134092129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542830735 | chr6:134092197-134092198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563893831 | chr6:134092200-134092201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs559543303 | chr6:134092228-134092229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs573163555 | chr6:134092245-134092246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs377557910 | chr6:134092261-134092262 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570666319 | chr6:134092263-134092264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188882982 | chr6:134092350-134092351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs72978181 | chr6:134092402-134092403 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs150567319 | chr6:134092450-134092451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181894744 | chr6:134092620-134092621 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184846324 | chr6:134092637-134092638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs78090316 | chr6:134092646-134092647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs144523185 | chr6:134092649-134092650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147849917 | chr6:134092674-134092675 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566075574 | chr6:134092679-134092680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs74480270 | chr6:134092772-134092773 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113336066 | chr6:134092790-134092791 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144603554 | chr6:134092822-134092823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536624707 | chr6:134092878-134092879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565982794 | chr6:134092900-134092901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs189405941 | chr6:134092933-134092934 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs181379005 | chr6:134092993-134092994 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs535954663 | chr6:134093046-134093047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs536614483 | chr6:134093060-134093061 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185190996 | chr6:134093128-134093129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21785460 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:134086200-134112400 | Weak transcription | Aorta | Aorta |
2 | chr6:134089000-134092400 | Weak transcription | NHLF | lung |
3 | chr6:134089000-134095400 | Weak transcription | A549 | lung |
4 | chr6:134090800-134091800 | Weak transcription | Fetal Stomach | stomach |
5 | chr6:134090800-134093400 | Weak transcription | Stomach Smooth Muscle | stomach |
6 | chr6:134090800-134095400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr6:134091000-134092000 | Weak transcription | Fetal Lung | lung |
8 | chr6:134091000-134095000 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
9 | chr6:134091000-134095200 | Weak transcription | Muscle Satellite Cultured Cells | -- |
10 | chr6:134091000-134095400 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr6:134091000-134095400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr6:134091000-134095400 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
13 | chr6:134091000-134095400 | Weak transcription | Osteobl | bone |
14 | chr6:134091000-134095600 | Weak transcription | NHDF-Ad | bronchial |
15 | chr6:134091000-134100000 | Weak transcription | Rectal Smooth Muscle | rectum |
16 | chr6:134091200-134092000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
17 | chr6:134091200-134095800 | Weak transcription | HSMM | muscle |
18 | chr6:134091800-134092000 | Enhancers | Fetal Stomach | stomach |
19 | chr6:134092000-134092200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
20 | chr6:134092000-134094800 | Enhancers | Fetal Lung | lung |
21 | chr6:134092200-134092400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
22 | chr6:134092400-134092600 | Enhancers | NHLF | lung |